Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Non Operating Income (2019 - 2025)

Pulmonx (LUNG) has disclosed Non Operating Income for 7 consecutive years, with $758000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income rose 477.11% to $758000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $886000.0, a 597.75% increase, with the full-year FY2024 number at $256000.0, up 138.04% from a year prior.
  • Non Operating Income was $758000.0 for Q3 2025 at Pulmonx, up from -$116000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $758000.0 in Q3 2025 to a low of -$432000.0 in Q3 2022.
  • A 5-year average of -$32722.2 and a median of -$106000.0 in 2021 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: tumbled 277.61% in 2023, then surged 477.11% in 2025.
  • Pulmonx's Non Operating Income stood at -$383000.0 in 2021, then skyrocketed by 152.48% to $201000.0 in 2022, then crashed by 277.61% to -$357000.0 in 2023, then surged by 121.57% to $77000.0 in 2024, then soared by 884.42% to $758000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Non Operating Income are $758000.0 (Q3 2025), -$116000.0 (Q2 2025), and $167000.0 (Q1 2025).